How to Reach Us Corporate Office 124 Washington Street, Suite 101 Foxboro, MA 02035 1.508.549.5710 1.508.543.4114 (Fax) For All Orders or Order Information, please send an email to PurchaseOrders@corgenix.com or call (303) 453-8955 For general inquiries, please email us
Location: United States, Massachusetts, Waltham
Total raised: $55M
Investors 1
| Date | Name | Website |
| - | Gilde Heal... | gildehealt... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 01.03.2012 | - | $15M | - |
| 17.07.2008 | Series D | $40M | - |
Mentions in press and media 16
| Date | Title | Description |
| 03.11.2015 | Shell’s chief executive Ben van Beurden announces an extra $1bn of savings to make $70bn BG deal work with low oil prices | |
| 05.01.2015 | British BG Group Receives $350m Payment From Egypt | British energy firm, BG Group, has confirmed the receipt of a $350 million payment from the Egyptian government. This payment is part of the overall repayment scheme to clear debt owed to the Egyptian energy sector, for which BG Group is a ... |
| 06.10.2014 | BG Group receives $350m from Egyptian government | - |
| 01.03.2012 | BG Medicine Receives $15M Loan from GE Capital | BG Medicine, Inc., a Waltham, Massachusetts-based life sciences company, has received a $15 million multi-draw senior secured term loan facility from GE Capital, Healthcare Financial Services. The company intends to use the financing for it... |
| 10.12.2010 | Report: BG Medicine could launch $71 million IPO next week | BG Medicine Inc. is reportedly planning to launch its $71.2 million initial public offering as soon as next week. The Waltham, Mass.-based diagnostics firm is expected to price 4.75 million shares at $13 to $15, according to a Securities &a... |
| 29.01.2010 | BG Medicine readies $86 million IPO | BG Medicine Inc. is getting in front of what is quickly becoming a throng, filing documents Jan. 29 for a $86.25 million initial public stock offering. The bid comes almost exactly two years to the day after the Waltham, Mass.-based biomark... |
| 17.07.2008 | BG Medicine Closes $40 Million in Series D Financing | Funds to accelerate launch of diagnostic products to enable Biomarker-Guided Medicine Waltham, Mass., BG Medicine, a life sciences company focused on the discovery, development and commercialization of novel molecular diagnostics based on ... |
| 17.07.2008 | BG Medicine Raises $40M | Share Share on Facebook Share on Twitter LinkedIn Email Reprints BG Medicine, a molecular diagnostics firm in Waltham, MA, announced today that it has closed a Series D financing round worth $40 million. Legg Mason Capital Management, GE As... |
| 07.02.2008 | IPO roundup: Is the window slamming on life sciences? | It’s sure starting to look that way. News that Archemix, a Cambridge, Mass., developer of aptamer-based drugs, yesterday withdrew its $72.5 million IPO follows closely on the heels of several other recent several other IPO collapses, includ... |
| 23.01.2008 | Life sciences briefing: Wednesday, Jan. 23, 2008 | TODAY’S HEADLINES: Mauna Kea Tech raises $30M for in-vivo cellular imaging (release) Knopp Neuro takes in $10M for Lou Gehrig’s drug (release) Cardiovascular Systems, arterial-plaque device maker, files for $86M IPO (Edgar) Diagnostics make... |
Show more